• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15922 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2008 HAYES, Inc. Methylenetetrahydrofolate Reductase (MTHFR) C677T for risk assessment for venous thromboembolism (VTE) or obstetric complications
2008 HAYES, Inc. PGxPredic: Rituximab Test (PGxHealth) for FCGR3A variants in follicular CD20-positive non-Hodgkin's Lymphoma
2008 HAYES, Inc. Prader-Willi Syndrome (PWS)
2008 HAYES, Inc. Primary Dystonia Type 1 (DYT1/TOR1A)
2008 HAYES, Inc. Prothrombin G20210A for risk assessment for venous thromboembolism (VTE) or obstetric complications
2008 HAYES, Inc. Thrombosis panel for risk assessment for venous thromboembolism (VTE) or obstetric complications
2008 HAYES, Inc. Uniparental disomy (UPD) for chromosomes 6, 7, 11, 14, or 15
2008 HAYES, Inc. Y chromosome microdeletions in male infertility
2008 HAYES, Inc. Gene expression profiling for prognosis of recurrence of primary breast cancer
2008 HAYES, Inc. Ashkenazi Jewish genetic carrier screening panel
2008 Medical Advisory Secretariat (MAS) Prevention of falls and fall-related injuries in community-dwelling seniors: an evidence-based analysis
2008 Medical Advisory Secretariat (MAS) Behavioural interventions for urinary incontinence in community-dwelling seniors: an evidence-based analysis
2008 Medical Advisory Secretariat (MAS) Caregiver- and patient-directed interventions for dementia: an evidence-based analysis
2008 Medical Advisory Secretariat (MAS) Social isolation in community-dwelling seniors: an evidence-based analysis
2008 Medical Advisory Secretariat (MAS) The falls/fractures economic model in Ontario residents aged 65 years and over (FEMOR)
2008 Norwegian Knowledge Centre for the Health Services (NOKC) Non-pharmacological interventions to reduce the risk for cardiovascular disease: a summary of systematic reviews
2008 Norwegian Knowledge Centre for the Health Services (NOKC) Graduated compression stockings for prevention of deep vein thrombosis
2008 Blue Cross Blue Shield Association (BCBS) CYP2D6 pharmacogenomics of tamoxifen treatment
2008 Blue Cross Blue Shield Association (BCBS) Pharmacogenomics-based treatment of helicobacter pylori infection
2008 Blue Cross Blue Shield Association (BCBS) Cognitive rehabilitation for traumatic brain injury in adults
2008 Blue Cross Blue Shield Association (BCBS) Autologous progenitor cell therapy for the treatment of ischemic heart disease
2008 Blue Cross Blue Shield Association (BCBS) Percutaneous vertebroplasty or kyphoplasty for vertebral fractures caused by osteoporosis or malignancy
2008 Blue Cross Blue Shield Association (BCBS) KRAS mutations and epidermal growth factor receptor inhibitor therapy in metastatic colorectal cancer
2008 Blue Cross Blue Shield Association (BCBS) Special report: recent developments in prostate cancer genetics and genetic testing
2008 Blue Cross Blue Shield Association (BCBS) Special report: MEG and MSI for the purpose of presurgical localization of epileptic lesions - a challenge for technology evaluation
2008 Blue Cross Blue Shield Association (BCBS) Special report: early intensive behavioral intervention based on applied behavior analysis among children with autism spectrum disorders
2008 Blue Cross Blue Shield Association (BCBS) Special report: aCGH for the genetic evaluation of patients with developmental delay/mental retardation or autism spectrum disorder
2008 Blue Cross Blue Shield Association (BCBS) Radiofrequency catheter ablation of the pulmonary veins for treatment of atrial fibrillation
2008 NIHR Health Technology Assessment programme Rapid systematic review of the impact of participation in research
2008 The Swedish Council on Health Technology Assessment (SBU) Moderately elevated blood pressure
2008 Health Information and Quality Authority (HIQA) The role of human papillomavirus vaccines in reducing the risk of cervical cancer in Ireland
2008 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for metastatic gastric cancer - first line in combination with capecitabine and cisplatin
2008 NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin for moderate to severe plaque psoriasis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Oxabact for primary hyperoxaluria
2008 NIHR Horizon Scanning Centre (NIHR HSC) Telcagepant for acute migraine
2008 NIHR Horizon Scanning Centre (NIHR HSC) Dirucotide for secondary progressive multiple sclerosis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (HuMax-CD20) in combination with methotrexate for rheumatoid arthritis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Aripiprazole (Abilify) for schizophrenia in children and adolescents
2008 NIHR Horizon Scanning Centre (NIHR HSC) Aripiprazole (Abilify) for children and adolescents with bipolar disorder
2008 NIHR Horizon Scanning Centre (NIHR HSC) Canakinumab for cryopyrin associated periodic syndrome
2008 NIHR Horizon Scanning Centre (NIHR HSC) Prucalopride (Resolor) for chronic constipation
2008 NIHR Horizon Scanning Centre (NIHR HSC) AVE0010 (ZP10) for type 2 diabetes mellitus
2008 NIHR Horizon Scanning Centre (NIHR HSC) Insulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children
2008 NIHR Horizon Scanning Centre (NIHR HSC) Exenatide once-weekly for type 2 diabetes mellitus - second or third line
2008 NIHR Horizon Scanning Centre (NIHR HSC) Alteplase (Activase) for the early (up to 4.5 hours) treatment of acute ischaemic stroke
2008 NIHR Horizon Scanning Centre (NIHR HSC) Ezetimibe (Ezetrol) for hypercholesterolaemia in adolescents
2008 NIHR Horizon Scanning Centre (NIHR HSC) Picoplatin for small cell lung cancer - second line
2008 NIHR Horizon Scanning Centre (NIHR HSC) Decitabine for acute myeloid leukaemia
2008 NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (AMG162) for prevention of bone metastases in prostate cancer
2008 NIHR Horizon Scanning Centre (NIHR HSC) BIBW 2992 (Tovok) for advanced or metastatic non-small cell lung cancer after failure of at least one reversible EGFR inhibitor
2008 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) in combination with docetaxel for metastatic breast cancer - first line
2008 NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) for non small cell lung cancer advanced or metastatic-maintenance monotherapy
2008 NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (AMG162) for the prevention of therapy-induced bone loss in non-metastatic breast and prostate cancer
2008 NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (AMG 162) for bone metastases from solid tumours and multiple myeloma
2008 NIHR Horizon Scanning Centre (NIHR HSC) Amrubicin for small cell lung cancer - relapsed and/or refractory, extensive disease
2008 NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin (LX-211) for non-infectious uveitis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Rolofylline for acute heart failure
2008 NIHR Horizon Scanning Centre (NIHR HSC) Lorcaserin hydrochloride (APD-356) for obesity or overweight people with at least one co-morbidity
2008 NIHR Horizon Scanning Centre (NIHR HSC) Irbesartan (Aprovel) for heart failure with preserved systolic function
2008 NIHR Horizon Scanning Centre (NIHR HSC) Irbesartan (Aprovel) for prevention of cardiovascular complications in patients with persistent atrial fibrillation
2008 NIHR Horizon Scanning Centre (NIHR HSC) Imatinib (Glivec) for adjuvant therapy in gastrointestinal stromal tumours
2008 NIHR Horizon Scanning Centre (NIHR HSC) Idrabiotaparinux for the treatment of DVT and/or PE and secondary prevention of venous thromboembolism
2008 NIHR Horizon Scanning Centre (NIHR HSC) Glatiramer acetate (Copaxone) for a single demyelinating event with an active inflammatory process
2008 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Certican) for prophylaxis of organ rejection in renal or cardiac transplantation
2008 NIHR Horizon Scanning Centre (NIHR HSC) Entecavir (Baraclude) for chronic hepatitis B with associated decompensated liver disease
2008 NIHR Horizon Scanning Centre (NIHR HSC) Ecallantide (DX-88) for acquired angioedema
2008 NIHR Horizon Scanning Centre (NIHR HSC) DCVax-Brain for glioblastoma multiforme - newly diagnosed
2008 NIHR Horizon Scanning Centre (NIHR HSC) Dabigatran etexilate (Pradaxa) for stroke prevention in atrial fibrillation
2008 NIHR Horizon Scanning Centre (NIHR HSC) Dabigatran etexilate (Pradaxa) for acute symptomatic venous thromboembolism
2008 NIHR Horizon Scanning Centre (NIHR HSC) Clopidogrel (Plavix) in combination with aspirin for prevention of vascular events in patients with atrial fibrillation
2008 NIHR Horizon Scanning Centre (NIHR HSC) Clevudine (Levovir) for hepatitis B
2008 NIHR Horizon Scanning Centre (NIHR HSC) ChondroCelect for knee cartilage defects
2008 NIHR Horizon Scanning Centre (NIHR HSC) Bortezomib for relapsed and/or refractory follicular non-Hodgkins lymphoma
2008 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for glioblastoma multiforme - relapsed
2008 NIHR Horizon Scanning Centre (NIHR HSC) Belatacept for prophylaxis of organ rejection in renal transplantation
2008 NIHR Horizon Scanning Centre (NIHR HSC) AVE-5026 for the prevention of venous thromboembolism in patients at risk
2008 NIHR Horizon Scanning Centre (NIHR HSC) Apixaban for prevention of venous thromboembolism after joint replacement or with acute medical illness
2008 NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (AZD6140) for acute coronary syndrome
2008 NIHR Horizon Scanning Centre (NIHR HSC) Panitumumab (Vectibix) for first-line metastatic colorectal cancer
2008 NIHR Horizon Scanning Centre (NIHR HSC) Nilotinib (Tasigna) for gastrointestinal stromal tumours
2008 NIHR Horizon Scanning Centre (NIHR HSC) Nilotinib (Tasigna) for chronic myeloid leukaemia
2008 NIHR Horizon Scanning Centre (NIHR HSC) Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Mepolizumab (Bosatria) for hypereosinophilic syndrome - first line in combination with corticosteroids
2008 NIHR Horizon Scanning Centre (NIHR HSC) Icatibant (Firazyr) for acute hereditary angioedema
2008 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (RAD-001) for advanced gastroenteropancreatic neuroendocrine tumours
2008 NIHR Horizon Scanning Centre (NIHR HSC) Oral and inhaled treprostinil for pulmonary arterial hypertension: NYHA class III
2008 NIHR Horizon Scanning Centre (NIHR HSC) Transient elastography (FibroScan) for evaluating liver fibrosis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Taranabant (MK-0364) for obesity
2008 NIHR Horizon Scanning Centre (NIHR HSC) Saxagliptin (BMS 477118) for type 2 diabetes
2008 NIHR Horizon Scanning Centre (NIHR HSC) Saredutant (SR-48968) for depression and anxiety
2008 NIHR Horizon Scanning Centre (NIHR HSC) S-1 for advanced gastric cancer - first line therapy
2008 NIHR Horizon Scanning Centre (NIHR HSC) Pazopanib (GW786034) for advanced and/or metastatic renal cell carcinoma - first/second line
2008 NIHR Horizon Scanning Centre (NIHR HSC) Oncotype DX prognostic and predictive test for early breast cancer
2008 NIHR Horizon Scanning Centre (NIHR HSC) TroVax (MVA-5T4) for locally advanced or metastatic renal cell carcinoma – with first line therapy
2008 NIHR Horizon Scanning Centre (NIHR HSC) Methylnaltrexone (MOA-728) for postoperative ileus
2008 NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (MDX-010) for unresectable stage III or IV metastatic melanoma - first or second line treatment
2008 NIHR Horizon Scanning Centre (NIHR HSC) Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis
2008 NIHR Horizon Scanning Centre (NIHR HSC) Larotaxel for advanced pancreatic cancer: recurrent and/or metastatic - second line
2008 NIHR Horizon Scanning Centre (NIHR HSC) GV1001 for advanced and/or metastatic pancreatic cancer
2008 NIHR Horizon Scanning Centre (NIHR HSC) Fingolimod FTY720 for relapsing-remitting and primary progressive multiple sclerosis